269 related articles for article (PubMed ID: 10600036)
21. Are glycineB sites involved in the development of morphine tolerance?
Kotlińska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
22. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice.
Popik P; Kozela E; Pilc A
Br J Pharmacol; 2000 Jul; 130(6):1425-31. PubMed ID: 10903986
[TBL] [Abstract][Full Text] [Related]
23. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
[TBL] [Abstract][Full Text] [Related]
24. The effects of NMDA receptor antagonists on acute morphine antinociception in mice.
Kozela E; Popik P
Amino Acids; 2002; 23(1-3):163-8. PubMed ID: 12373532
[TBL] [Abstract][Full Text] [Related]
25. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
[TBL] [Abstract][Full Text] [Related]
26. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
27. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY
Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment.
Juni A; Klein G; Kowalczyk B; Ragnauth A; Kest B
Neuropharmacology; 2008 Jun; 54(8):1264-70. PubMed ID: 18457849
[TBL] [Abstract][Full Text] [Related]
30. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists.
Sevostianova N; Danysz W; Bespalov AY
Eur J Pharmacol; 2005 Nov; 525(1-3):83-90. PubMed ID: 16297905
[TBL] [Abstract][Full Text] [Related]
31. NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Brain Res Bull; 2005 Jan; 64(6):493-503. PubMed ID: 15639545
[TBL] [Abstract][Full Text] [Related]
32. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
Juni A; Klein G; Pintar JE; Kest B
Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
[TBL] [Abstract][Full Text] [Related]
33. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
[TBL] [Abstract][Full Text] [Related]
34. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
35. Effect of linalool on morphine tolerance and dependence in mice.
Hosseinzadeh H; Imenshahidi M; Hosseini M; Razavi BM
Phytother Res; 2012 Sep; 26(9):1399-404. PubMed ID: 22318903
[TBL] [Abstract][Full Text] [Related]
36. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Popik P; Danysz W
J Pharmacol Exp Ther; 1997 Feb; 280(2):854-65. PubMed ID: 9023300
[TBL] [Abstract][Full Text] [Related]
38. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
39. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
40. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Lutfy K; Doan P; Nugyen M; Weber E
Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]